Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial

Published:2021-03-12 Issue:3 Volume:36 Page:140-146
ISSN:0268-1315
Container-title:International Clinical Psychopharmacology
language:en
Short-container-title:

Author:

Farajollahi-Moghadam Mostafa,Sanjari-Moghaddam Hossein,Ghazizadeh Hasemi Maryam,Sanatian Zahra,Talaei Ali,Akhondzadeh Shahin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference48 articles.

1. Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study;Abbasi;J Affect Disord,2012

2. Lipoic acid and pentoxifylline mitigate nandrolone decanoate-induced neurobehavioral perturbations in rats via re-balance of brain neurotransmitters, up-regulation of Nrf2/HO-1 pathway, and down-regulation of TNFR1 expression;Ahmed;Horm Behav,2015

3. Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal;Akhondzadeh;J Clin Pharm Ther,2000

4. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial;Akhondzadeh;Depress Anxiety,2009

5. Modafinil as a treatment for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized clinical trial;Amiri;Prog Neuropsychopharmacol Biol Psychiatry,2008

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of pentoxifylline for the treatment of bipolar I/II patients with treatment-resistant depression: A proof-of-concept, randomized, double-blind, placebo-controlled trial;Brain Research Bulletin;2024-10

2. Pentoxifylline as a Novel Add-on Therapy for Major Depressive Disorder in Adult Patients: A Randomized, Double-Blind, Placebo-Controlled Trial;Pharmacopsychiatry;2024-05-06

3. A Critical View on New and Future Antidepressants;Clinical Psychopharmacology and Neuroscience;2024-02-15

4. Innovation in psychopharmacology;International Clinical Psychopharmacology;2023-07-10

5. Phosphodiesterase inhibitors in psychiatric disorders;Psychopharmacology;2023-04-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3